BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31955649)

  • 1. κ and λ urine free light chains: a new method for quantification.
    Giussani M; Ciniselli CM; Macciotta A; Panella R; Verderio P; Bonini C; Morelli D
    Tumori; 2020 Dec; 106(6):457-463. PubMed ID: 31955649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratio of urinary free immunoglobulin light chain kappa to lambda in the diagnosis of Bence Jones proteinuria.
    Nakano T; Nagata A; Takahashi H
    Clin Chem Lab Med; 2004 Apr; 42(4):429-34. PubMed ID: 15147154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
    J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical profile of Bence-Jones type multiple myeloma.
    Lyubimova NV; Timofeev YS; Abaev VM; Votyakova OM; Osmanov EA; Kushlinskii NE
    Klin Lab Diagn; 2022 Oct; 67(10):570-574. PubMed ID: 36315171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunoblotting procedure following agarose gel electrophoresis for detection of Bence Jones proteinuria compared with immunofixation and quantitative light chain determination.
    Withold W; Reinauer H
    Eur J Clin Chem Clin Biochem; 1995 Mar; 33(3):135-8. PubMed ID: 7605825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
    Levinson SS
    Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic reference range of κ/λ free light chain ratio to screen for Bence Jones proteinuria is not significantly influenced by GFR.
    Schmidt-Hieltjes Y; Elshof C; Roovers L; Ruinemans-Koerts J
    Eur J Haematol; 2016 May; 96(5):527-31. PubMed ID: 26172558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new concept for detection of Bence Jones proteinuria in patients with monoclonal gammopathy.
    Hofmann W; Garbrecht M; Bradwell AR; Guder WG
    Clin Lab; 2004; 50(3-4):181-5. PubMed ID: 15074473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An algorithmic approach using kappa/lambda ratios to improve the diagnostic accuracy of urine protein electrophoresis and to reduce the volume required for immunoelectrophoresis.
    Levinson SS
    Clin Chim Acta; 1997 Jun; 262(1-2):121-30. PubMed ID: 9204214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies.
    Hill PG; Forsyth JM; Rai B; Mayne S
    Clin Chem; 2006 Sep; 52(9):1743-8. PubMed ID: 16858075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
    Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
    Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
    Bradwell AR; Carr-Smith HD; Mead GP; Tang LX; Showell PJ; Drayson MT; Drew R
    Clin Chem; 2001 Apr; 47(4):673-80. PubMed ID: 11274017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of utility of free light chain-specific antibodies in the urine immunofixation test.
    Lueck N; Agrawal YP
    Clin Chem; 2006 May; 52(5):906-7. PubMed ID: 16638965
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach for the chromatographic purification and peptide mass fingerprinting of urinary free light chains.
    Mali BC; Badgujar SB; Shukla KK; Bhanushali PB
    Int J Biol Macromol; 2017 Feb; 95():331-339. PubMed ID: 27888009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy.
    Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ
    Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Bence-Jones protein by isoelectric focussing of unconcentrated urine followed by nitrocellulose blotting and immunoperoxidase staining.
    Norden AG; Fulcher LM; Flynn FV
    Clin Chim Acta; 1985 Dec; 153(3):149-56. PubMed ID: 3935344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.